Literature DB >> 19553663

Mechanism of Epac activation: structural and functional analyses of Epac2 hinge mutants with constitutive and reduced activities.

Tamara Tsalkova1, Donald K Blumenthal, Fang C Mei, Mark A White, Xiaodong Cheng.   

Abstract

Epac2 is a member of the family of exchange proteins directly activated by cAMP (Epac). Our previous studies suggest a model of Epac activation in which cAMP binding to the enzyme induces a localized "hinge" motion that reorients the regulatory lobe relative to the catalytic lobe without inducing large conformational changes within individual lobes. In this study, we identified the location of the major hinge in Epac2 by normal mode motion correlation and structural alignment analyses. Targeted mutagenesis was then performed to test the functional importance of hinge bending for Epac activation. We show that substitution of the conserved residue phenylalanine 435 with glycine (F435G) facilitates the hinge bending and leads to a constitutively active Epac2 capable of stimulating nucleotide exchange in the absence of cAMP. In contrast, substitution of the same residue with a bulkier side chain, tryptophan (F435W), impedes the hinge motion and results in a dramatic decrease in Epac2 catalytic activity. Structural parameters determined by small angle x-ray scattering further reveal that whereas the F435G mutant assumes a more extended conformation in the absence of cAMP, the F435W mutant is incapable of adopting the fully extended and active conformation in the presence of cAMP. These findings demonstrate the importance of hinge motion in Epac activation. Our study also suggests that phenylalanine at position 435 is the optimal size side chain to keep Epac closed and inactive in the absence of cAMP while still allowing the proper hinge motion for full Epac extension and activation in the presence of cAMP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19553663      PMCID: PMC2749139          DOI: 10.1074/jbc.M109.024950

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Characterization of the activation of the Rap-specific exchange factor Epac by cyclic nucleotides.

Authors:  Holger Rehmann
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

2.  The cAMP binding domain: an ancient signaling module.

Authors:  Helen M Berman; Lynn F Ten Eyck; David S Goodsell; Nina M Haste; Alexandr Kornev; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-23       Impact factor: 11.205

3.  Interplay between exchange protein directly activated by cAMP (Epac) and microtubule cytoskeleton.

Authors:  Fang C Mei; Xiaodong Cheng
Journal:  Mol Biosyst       Date:  2005-09-26

4.  Dissecting the mechanism of Epac activation via hydrogen-deuterium exchange FT-IR and structural modeling.

Authors:  Shaoning Yu; Fenghui Fan; Samuel C Flores; Fang Mei; Xiaodong Cheng
Journal:  Biochemistry       Date:  2006-12-05       Impact factor: 3.162

5.  Conformational analysis of Epac activation using amide hydrogen/deuterium exchange mass spectrometry.

Authors:  Melissa Brock; Fenghui Fan; Fang C Mei; Sheng Li; Christopher Gessner; Virgil L Woods; Xiaodong Cheng
Journal:  J Biol Chem       Date:  2007-09-04       Impact factor: 5.157

Review 6.  Capturing cyclic nucleotides in action: snapshots from crystallographic studies.

Authors:  Holger Rehmann; Alfred Wittinghofer; Johannes L Bos
Journal:  Nat Rev Mol Cell Biol       Date:  2007-01       Impact factor: 94.444

7.  Crystal structure of a complex between the catalytic and regulatory (RIalpha) subunits of PKA.

Authors:  Choel Kim; Nguyen-Huu Xuong; Susan S Taylor
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

Review 8.  Epac and PKA: a tale of two intracellular cAMP receptors.

Authors:  Xiaodong Cheng; Zhenyu Ji; Tamara Tsalkova; Fang Mei
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2008-07       Impact factor: 3.848

9.  PKA type IIalpha holoenzyme reveals a combinatorial strategy for isoform diversity.

Authors:  Jian Wu; Simon H J Brown; Sventja von Daake; Susan S Taylor
Journal:  Science       Date:  2007-10-12       Impact factor: 47.728

10.  Evolution of allostery in the cyclic nucleotide binding module.

Authors:  Natarajan Kannan; Jian Wu; Ganesh S Anand; Shibu Yooseph; Andrew F Neuwald; J Craig Venter; Susan S Taylor
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more
  29 in total

1.  Rp-cAMPS Prodrugs Reveal the cAMP Dependence of First-Phase Glucose-Stimulated Insulin Secretion.

Authors:  Frank Schwede; Oleg G Chepurny; Melanie Kaufholz; Daniela Bertinetti; Colin A Leech; Over Cabrera; Yingmin Zhu; Fang Mei; Xiaodong Cheng; Jocelyn E Manning Fox; Patrick E MacDonald; Hans-G Genieser; Friedrich W Herberg; George G Holz
Journal:  Mol Endocrinol       Date:  2015-06-10

2.  Critical role for Epac1 in inflammatory pain controlled by GRK2-mediated phosphorylation of Epac1.

Authors:  Pooja Singhmar; XiaoJiao Huo; Niels Eijkelkamp; Susana Rojo Berciano; Faiza Baameur; Fang C Mei; Yingmin Zhu; Xiaodong Cheng; David Hawke; Federico Mayor; Cristina Murga; Cobi J Heijnen; Annemieke Kavelaars
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

Review 3.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

4.  5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP.

Authors:  Haijun Chen; Tamara Tsalkova; Fang C Mei; Yaohua Hu; Xiaodong Cheng; Jia Zhou
Journal:  Bioorg Med Chem Lett       Date:  2012-04-26       Impact factor: 2.823

5.  Allosteric inhibition of Epac: computational modeling and experimental validation to identify allosteric sites and inhibitors.

Authors:  Loren M Brown; Kathleen E Rogers; Nakon Aroonsakool; J Andrew McCammon; Paul A Insel
Journal:  J Biol Chem       Date:  2014-09-02       Impact factor: 5.157

6.  Isoform-specific antagonists of exchange proteins directly activated by cAMP.

Authors:  Tamara Tsalkova; Fang C Mei; Sheng Li; Oleg G Chepurny; Colin A Leech; Tong Liu; George G Holz; Virgil L Woods; Xiaodong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

7.  A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion.

Authors:  Muayad Almahariq; Tamara Tsalkova; Fang C Mei; Haijun Chen; Jia Zhou; Sarita K Sastry; Frank Schwede; Xiaodong Cheng
Journal:  Mol Pharmacol       Date:  2012-10-11       Impact factor: 4.436

8.  Pancreatic Beta Cell G-Protein Coupled Receptors and Second Messenger Interactions: A Systems Biology Computational Analysis.

Authors:  Leonid E Fridlyand; Louis H Philipson
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

Review 9.  Cyclic AMP sensor EPAC proteins and energy homeostasis.

Authors:  Muayad Almahariq; Fang C Mei; Xiaodong Cheng
Journal:  Trends Endocrinol Metab       Date:  2013-11-12       Impact factor: 12.015

10.  Identification and characterization of small molecules as potent and specific EPAC2 antagonists.

Authors:  Haijun Chen; Tamara Tsalkova; Oleg G Chepurny; Fang C Mei; George G Holz; Xiaodong Cheng; Jia Zhou
Journal:  J Med Chem       Date:  2013-01-15       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.